Article
SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
20 Nov 2014
Abstract excerpt
SRT1720 is an activator of SIRT1, a NAD(+)-dependent protein and histone deacetylase that plays an important role in numerous biologic processes. Several studies have illustrated that SRT1720 treatment could improve metabolic conditions in mouse models and in a study in cancer SRT1720 caused increased apoptosis of myeloma cells. However, the effect of SRT1720 on cancer may be complex, as some recent studies have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
